Evolution of the joint International Atomic Energy Agency (IAEA), International Agency for Research on Cancer (IARC), and WHO cancer control assessments (imPACT Reviews)
Abstract
Before 2005, cancer and other non-communicable diseases were not yet health and development agenda priorities. Since the 2005 World Health Assembly Resolution, which encouraged WHO, the International Agency for Research on Cancer (IARC), and the International Atomic Energy Agency (IAEA) to jointly work on cancer control, progress was achieved in low-income and middle-income countries on a small scale. Recently, rapid acceleration in UN collaboration and global cancer activities has focused attention in global cancer control. This Policy Review presents the evolution of the IAEA, IARC, and WHO joint advisory service to help countries assess needs and capacities throughout the comprehensive cancer control continuum. We also highlight examples per country, showcasing a snapshot of global good practices to foster an exchange of experiences for continuous improvement in the integrated mission of Programme of Action for Cancer Therapy (imPACT) reviews and follow-up support. The future success of progress in cancer control lies in the high-level political and financial commitments. Linking the improvement of cancer services to the strengthening of health systems after the COVID-19 pandemic will also ensure ongoing advances in the delivery of care across the cancer control continuum.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The IAEA and WHO assist member states by providing technical guidance, training, and facilitating surveys.
“The International Atomic Energy Agency (IAEA) and the World Health Organization (WHO) assist member states by providing technical guidance, training, and facilitating surveys.98–100”
From Computed Tomography Diagnostic Reference Levels Worldwide and in Jordan: Implications for Patient Dose Reduction (2026) · cites this paper as [99]
Cites
Abdel-Wahab, M., Lahoupe, B., Polo, A., Zubizarreta, E., Adnan, R. R., Johnston, P., Juric, A., Haffar, F. E., Andre, M., & Meghzifene, A. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30372-8 · Cited by 18 · see citing works
Self-citationLatino, N. J., Galotti, M., Cherny, N. I., de Vries, E. G. E., Douillard, J.-Y., Kaidarova, D., & Ilbawi, A. (2022) · ESMO Open · doi:10.1016/j.esmoop.2021.100362 · Cited by 16 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Oglat, A., Shdaifat, S., Sayah, M., Abukonna, A., & Khogali, W. (2026) · Drug, Healthcare and Patient Safety · doi:10.2147/dhps.s595721
- Authors
- Veljkovikj, I., Ilbawi, A. M., Roitberg, F., Luciani, S., Barango, P., Corbex, M., Dorji, G., Gunawardena, N., Johnson, S., Juric, A., Siewert, K., Saporiti, G., Nobile, M., Sauvaget, C., Vidanapathirana, J., Wright, B., Lishimpi, K., Kaidarova, D., Pomata, A., Malick, A., Dangou, J. M., Abdel-Wahab, M., Weiderpass, E., Mikkelsen, B., & Stevens, L. M.
- Affiliations
- International Atomic Energy Agency (AT)
- World Health Organization (CH)
- World Health Organization Regional Office for the Americas (US)
- World Health Organization Regional Office for Europe (DK)
- Union for International Cancer Control (CH)
- Centre international de recherche sur le cancer (FR)
- Ministry of Health (JM)
- Ministry of Health (ZM)
- Kazakh Institute of Oncology and Radiology (KZ)
- Ministerio de Salud Pública y Bienestar Social (PY)
- World Health Organization Regional Office for Africa (CG)
- Corresponding author
- Veljkovikj, Igor
- ORCID
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2022-10
- Volume
- 23
- Issue
- 10
- Pages
- e459-e468
- ISSN
- 1470-2045 (ISSN-L)
- OpenAlex
- W4297102188
- Cited by
- 23
- References
- 2
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 3 · 2023: 3 · 2022: 1
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advances in Oncology and Radiotherapy
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Social Sciences › Business, Management and Accounting › Organizational Behavior and Human Resource Management › Global Public Health Policies and Epidemiology
- Keywords
- cancer control, International Atomic Energy Agency, International Agency for Research on Cancer, World Health Organization, international cooperation, low- and middle-income countries, cancer control continuum, health system strengthening, oncology services, non-communicable diseases, World Health Assembly resolution, COVID-19 pandemic
- MeSH terms
- COVID-19, Humans, International Agencies, Neoplasms, Nuclear Energy, World Health Organization, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
